Open Access Open Access  Restricted Access Subscription Access

Exploring the Influencing Factors of COVID-19 Vaccine Acceptance Among Bangladeshi People

Md. Mahbube Azizul Hakim, Md. Farhaduzzaman Bhuiyan, Nahid Salma


This study attempts to identify the factors that led individuals to take the COVID-19 vaccine, as well as their concerns regarding the vaccine and vaccination campaign. Results indicated that respondents had a favorable impression of the government’s initiative. Where the majority of participants were male, 258 people who got at least one dose of either of the authorized COVID-19 vaccines were included in this study. The Cochran formula was used to determine the sample size. The Sinopharm vaccination was provided to the majority of respondents (51.94%), while 33% received the secondhighest dose of AstraZeneca. Family members have taken the COVID-19 vaccine was the most influencing factors (39.5%) behind taking vaccine. Among other factors: opportunity to receive it for free (33.3%), social responsibility (22.9%), and people found very much optimistic about the vaccination program as well (13.6%). They had no doubts about the vaccine’s availability or authenticity (13.2%). Any immediate reaction after taking the vaccine is also not reported by any of the respondents. The findings from the analysis would be a great help for the government, health care departments and policy makers to make better decisions regarding COVID-19 vaccine.


COVID-19, coronavirus, vaccine, vaccination campaign, astraZeneca, Sinopharm

Full Text:



Lone SA, Ahmad A. COVID-19 pandemic–an African perspective. Emerg Microbes Infect. 2020;9(1):1300-8. doi: 10.1080/22221751.2020.1775132, PMID 32458760.

Mahmud S, Mohsin M, Khan IA, Mian AU, Zaman MA. Knowledge, beliefs, attitudes and perceived risk about COVID-19 vaccine and determinants of COVID-19 vaccine acceptance in Bangladesh. PLOS ONE. 2021; 16 (9): e0257096. doi: 10.1371/journal.pone.0257096, PMID 34499673.

World Health Organization. (2022). Weekly epidemiological update on COVID-19-15 June 2022. [Online] Available December 10, 2022, from at [Accessed on February 2023]

Islam MT, Talukder AK, Siddiqui MN, Islam T. Tackling the COVID-19 pandemic: the Bangladesh perspective. J Public Health Res. 2020; 9 (4): 1794. doi: 10.4081/jphr.2020.1794, PMID 33117758.

Kumar V, Alshazly H, Idris SA, Bourouis S. Evaluating the impact of COVID-19 on society, environment, economy, and education. Sustainability. 2021; 13 (24): 13642. doi: 10.3390/SU132413642.

GWD. (n.d.). COVID-19 vaccine update from Bangladesh. [Online] Available at [Accessed on February 2023]

Hossain MB, Alam MZ, Islam MS, Sultan S, Faysal MM, Rima S et al. COVID-19 vaccine hesitancy among the adult population in Bangladesh: a nationwide cross-sectional survey. PLOS ONE. 2021; 16 (12): e0260821. doi: 10.1371/journal.pone.0260821, PMID 34882726.

Mahmud-Al-Rafat A, Hewins B, Mannan A, Kelvin DJ, Billah MM. COVID-19 vaccine inequity, dependency, and production capability in low-income and middle-income countries: the case of Bangladesh. Lancet Infect Dis. 2022; 22 (3): 310–312. doi: 10.1016/S1473-3099(22)00028-7, PMID 35101243.

Riad A, Pokorná A, Attia S, Klugarová J, Koščík M, Klugar M. Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic. J Clin Med. 2021; 10 (7): 1428. doi: 10.3390/jcm10071428, PMID 33916020.

Ali M, Hossain A. What is the extent of COVID-19 vaccine hesitancy in Bangladesh? A cross-sectional rapid national survey. BMJ Open. 2021; 11 (8): e050303. doi: 10.1136/bmjopen-2021-050303, PMID 34429316.

Ahmad Chaudhary F, Ahmad B, Danial Khalid M, Fazal A, Mohsin Javaid M, Qasim Butt D et al. Hum Vaccin Immunother. 2021; 17 (10): 3365–3370. doi: 10.1080/21645515.2021.1944743.


  • There are currently no refbacks.

Copyright (c) 2022 Current Trends in Information Technology

  • eISSN: 2249-4707
  • ISSN: 2348-7895